Guggenheim started coverage on shares of Anthem (NASDAQ:ANTX – Free Report) in a research report released on Monday,Benzinga reports. The brokerage issued a buy rating and a $9.00 target price on the stock.
ANTX has been the subject of a number of other reports. Wall Street Zen upgraded Anthem from a “sell” rating to a “hold” rating in a research note on Sunday, June 14th. Leerink Partners upgraded Anthem from a “market perform” rating to an “outperform” rating and set a $9.00 price target on the stock in a research report on Thursday, May 14th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Anthem in a report on Monday, July 6th. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $9.00.
Check Out Our Latest Analysis on Anthem
Anthem Stock Performance
Anthem (NASDAQ:ANTX – Get Free Report) last posted its quarterly earnings results on Monday, May 11th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.23) by ($0.06).
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in the stock. Spruce Street Capital LP acquired a new position in shares of Anthem during the first quarter valued at approximately $5,576,000. OMERS ADMINISTRATION Corp bought a new stake in Anthem during the first quarter worth approximately $54,000. Commodore Capital LP acquired a new stake in Anthem in the first quarter worth approximately $7,981,000. ADAR1 Capital Management LLC acquired a new stake in Anthem in the first quarter worth approximately $47,000. Finally, Ally Bridge Group NY LLC bought a new position in Anthem during the 1st quarter valued at $1,800,000. 90.47% of the stock is currently owned by institutional investors.
Anthem Company Profile
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.
Further Reading
- Five stocks we like better than Anthem
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.
